1. Home
  2. TECH vs ALLY Comparison

TECH vs ALLY Comparison

Compare TECH & ALLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • ALLY
  • Stock Information
  • Founded
  • TECH 1976
  • ALLY 1919
  • Country
  • TECH United States
  • ALLY United States
  • Employees
  • TECH N/A
  • ALLY N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • ALLY Major Banks
  • Sector
  • TECH Health Care
  • ALLY Finance
  • Exchange
  • TECH Nasdaq
  • ALLY Nasdaq
  • Market Cap
  • TECH 12.5B
  • ALLY 13.6B
  • IPO Year
  • TECH 1989
  • ALLY 2014
  • Fundamental
  • Price
  • TECH $74.78
  • ALLY $35.12
  • Analyst Decision
  • TECH Buy
  • ALLY Buy
  • Analyst Count
  • TECH 9
  • ALLY 20
  • Target Price
  • TECH $80.67
  • ALLY $39.47
  • AVG Volume (30 Days)
  • TECH 860.3K
  • ALLY 5.4M
  • Earning Date
  • TECH 10-29-2024
  • ALLY 10-18-2024
  • Dividend Yield
  • TECH 0.43%
  • ALLY 3.42%
  • EPS Growth
  • TECH N/A
  • ALLY N/A
  • EPS
  • TECH 1.05
  • ALLY 2.32
  • Revenue
  • TECH $1,159,060,000.00
  • ALLY $6,777,000,000.00
  • Revenue This Year
  • TECH $6.90
  • ALLY N/A
  • Revenue Next Year
  • TECH $9.69
  • ALLY $11.66
  • P/E Ratio
  • TECH $71.22
  • ALLY $15.11
  • Revenue Growth
  • TECH 1.97
  • ALLY N/A
  • 52 Week Low
  • TECH $51.79
  • ALLY $22.54
  • 52 Week High
  • TECH $85.57
  • ALLY $45.46
  • Technical
  • Relative Strength Index (RSI)
  • TECH 47.19
  • ALLY 42.93
  • Support Level
  • TECH $73.89
  • ALLY $34.05
  • Resistance Level
  • TECH $80.12
  • ALLY $35.59
  • Average True Range (ATR)
  • TECH 2.52
  • ALLY 0.88
  • MACD
  • TECH -0.25
  • ALLY 0.31
  • Stochastic Oscillator
  • TECH 12.61
  • ALLY 80.08

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About ALLY Ally Financial Inc.

Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.

Share on Social Networks: